Navigation Links
The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
Date:12/1/2008

bject to risks and uncertainties, and Westaim can give no assurance that these expectations are correct. Various factors could cause actual results to differ materially from those projected in such statements, including but not limited to statements regarding Westaim's intention to review its alternatives for maximizing the value of its stake in Nucryst, the expected strengthening of Westaim's cash position on a return of capital by Nucryst, and pursuit of new investment opportunities to grow the value of the company and to realize maximum returns for shareholders. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise. Accordingly, readers are advised not to place undue reliance on forward-looking statements, and should not rely on this information at any date other than the date of this news release. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.


'/>"/>
SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Westaim announces 2008 third quarter results
2. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
3. Westaim terminates reorganization agreement and cancels shareholders meeting
4. Westaim to deregister its common stock in the United States
5. Westaim announces sale of iFire Technology Ltd. assets
6. Westaim announces 2008 second quarter results
7. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
8. Westaim announces 2008 first quarter results
9. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
10. Westaim announces 2007 year-end results
11. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ARP Praises House Passage of Health Care Reform Bi...edicare, improve coverage for all Americans ,,... -- ,, SUMMARY: Last night the United States...are reform legislation that would strengthen Medic...e companies that prices millions of Americans out ...
(Date:11/8/2009)...gher Costs and Crushing Taxes Nail Nation,s Job Cr...wire/ -- In response to U.S. House passage of the ... Entrepreneurship Council (SBE Council) president ...ement: ,, "Make no mistake, those voting for H... with higher costs and crushing taxes and penaltie...
(Date:11/8/2009)... 3D Global Solutions is pleased t...managing the proposal effort for ReSound who recen...al Hearing Aid contract. The award includes not on...tment of Defense and other federal agencies. , ...r 8, 2009 -- 3D Global Solutions is pleased to ann...
(Date:11/8/2009)...SHINGTON, Nov. 7 Today,...itts, Kaptur, Dahlkemper, Smith, Ellsworth and Lip... America Act" (H.R. 3962). The amendment maintains...for abortion and for benefits packages that includ...ose who receive affordability credits and those wh...
(Date:11/8/2009)...SHINGTON, Nov. 8 Pharma...RMA) Senior Vice President Ken Johnson released th...are reform bill: ,, "We are disappointed, but n...ed by millions of hardworking Americans as well as...epresentatives who voted against the bill. ,, "...
Breaking Medicine News(10 mins):Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3
... found that Alzheimers drug Donepezil may help peo...rcelo Berthier of the M dico-Sanitarias Research C...y boosting neurons ability to communicate. ...prehend speech, of which stroke is the most common...
... how to talk in an effort to apprehend the appalli... A recent study revealed that half of the ki...the age of five. Therefore, ministers are...stures and symbols to develop vocabulary. ...
...one Institute of Neurological Disease (GIND) have ... can prevent seizures and neurological deficits r...ted today in the journal Science, demonstrate that...an. Reducing tau levels also made mice more resist...
...nd ducks from Matigara, Darjeeling District in Wes... for Avian Influenza (H5 & H7) as per report rece...(HSADL), Bhopal. Unusual mortality in birds had re...rds on 5-6th May, 2007. A team headed by Deputy Di...
...U.S are worried about falling rates in mammography...Cancer Institute and Centers for Disease Control ...ms for detection of breast cancer risk, have fal... replacement therapy or HRT. Rates of HRT fell si...
...ot only makes your blood boil in anger, but as a n...nces of having a heart attack. Researcher...vil servants working for the British government in...ng that I am being treated unfairly" on a scale of...
Other Medicine News:Health News:Toddlers to Be Trained to Improve Their Communication Skills 2Health News:New Strategy Identified for Preventing Acute and Chronic Brain Disease 2Health News:Mammogram Rates On The Decline In America 2Health News:Heart Attack Risk Increased by Unfair Treatment 2
(Date:11/7/2009)... Patients reported C1-esterase inhi... in treating acute swelling attacks at any body lo...r, according to data presented today at the 2009 A...y (ACAAI) Annual Meeting. The results come from a ...llel with the ongoing, prospective, open label I ...
(Date:11/6/2009)...ire-FirstCall/ -- Recession in domestic and intern...ied Healthcare Products in the first quarter of fi...les declines pushed Allied into a loss for the qua...,000, or negative 9 cents per share, compared to a... 3 cents per share. ,, Sales fell about 21 per...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Watson Pharmaceuticals, I...cal company, announced today that Paul Bisaro, Wat...provide an overview and update of the Company,s bu... Conference on Wednesday, November 11, 2009 at 12:...on will be webcast live and can be accessed on Wat...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Pelosi 3A Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 48773 1Pelosi 3A Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 48773 2Pelosi 3A Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 48773 3HealthSouth Declares Dividend on 6 5 25 Series A Convertible Perpetual Preferred Stock 48769 1Misonix Announces the Purchase of Patents From ProRhythm Inc 48765 1Misonix Announces the Purchase of Patents From ProRhythm Inc 48765 2Misonix Announces the Purchase of Patents From ProRhythm Inc 48765 3
...ompelling case for clinical testing in human ... Nov. 12 In its Oct. 15 issue, Cancer,Research pu...ration,describing successful eradication of human ...ovel oncolytic virus developed by Genelux scientis... for the use of GL-ONC1 in,human cancer patients. ...
...2 Allos,Therapeutics, Inc. (Nasdaq: ALTH ) today... a Phase 1, non-randomized, open-label, multi-cent... chemotherapeutic agent RH1 in,patients with advan... "We are pleased to advance the development of thi...al Officer of Allos. "RH1 is a small molecule,chem...
Other Medicine Technology:Tumor Eradication Article Published by Cancer Research 2Tumor Eradication Article Published by Cancer Research 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4
...ginal Vibratome Semi-Automatic Tissue Sectioning S...d tissue sectioning system. Researchers from aroun...sic for their fresh and fresh fixed tissue section...Automatic Tissue Sectioning Systems, the biologica...
...ratome 1000 Plus Sectioning System provides a vers...or plant tissues. The 1000 employs a vibrating bl...zing or embedding. The creation of artifacts, the...me activities, and other deleterious effects inher...
Specimen Mounting Blocks
Specimen Retrievers
Medicine Products: